In an ever-changing climate, the question of insulin access continues to cause concern among the diabetes community.  Todd Beaudroux, from our friends at Beyond Type 1, sat down with Wade Neucks, the Director of Patient Affordability Solutions Team at Lilly Diabetes, to discuss the details of the insulin supply chain and ease any concerns our community might have about being able to access insulin during the COVID-19 pandemic across the globe.

You can find the full interview on the Beyond Type 1 site located  HERE

For updates and information related to the type 1 diabetes community and COVID-19, please continue to follow JDRF’s response to this crisis on our dedicated webpage https://www.jdrf.org/coronavirus/